Summary
Jyseleca is indicated for the treatment of adult patients with moderately to severe active ulcerative colitis who have had an inadequate response with, lost response to, or were intolerant to either conventional therapy or a biologic agent.
This detail aid was created to help the HCP guide the patient through what JYSELECA has to offer.
